Financial Agenda 2018

Onxeo Announces its Financial Agenda for 2018

Paris (France), January 23, 2018 – 5:45 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo” or the “Company”), a biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant cancers, today announced its financial agenda for 2018.

Event

Date*

Full-year 2017 results

Thursday, March 29, 2018

Q1 2018 financial information

Friday, May 4, 2018

Shareholders’ general meeting

Wednesday, May 16, 2018

Half-year 2018 results

Friday, July 27, 2018

Q3 2018 financial information

Thursday, October 25, 2018

 * This preliminary agenda may be modified. Press releases are published after financial markets close.

180123_ONXEO_Agenda-2018_EN